Ledger.Open graph →
SEC Form D · filed May 26, 2020

Phoreus Biotechnology, Inc

Offering
$2.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OLATHE, KS
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Michael Coe · Perry, KSExec · DirectorRandall Tosh · Olathe, KSExec · DirectorChristopher Brandt · Manhattan, KSDirectorMatthew Tomich · New York, NYDirectorSteven Alecia · New York, NYDirectorAnkit Khandelwal · Naperville, ILExec · DirectorDavid Sze · San Francisco, CAExec · DirectorCindy Croissant · Poulsbo, WADirectorLynn Rundle · Palm Beach Gardens, FLDirectorGino Santini · Princeton, NJDirectorHerman Cukier · Princeton, NJDirectorDaniel Motto · Princeton, NJExec · DirectorJoseph Moye · Orlando, FLExec · DirectorLynn Rundle · Palm Beach Gardens, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗